ArticleCancer science2022
FGFR2 loss sensitizes MYCN-amplified neuroblastoma CHP134 cells to CHK1 inhibitor-induced apoptosis.
Kiyohiro Ando et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ArticleCancer science2022
Kiyohiro Ando et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.